Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine

2017 ◽  
Vol 89 (1) ◽  
pp. 11-12
Author(s):  
Arka Chatterjee ◽  
William B. Hillegass
Keyword(s):  
Precision Medicine ◽  
Percutaneous Intervention ◽  
Left Main ◽  
Left Main Disease ◽  
Unprotected Left Main Disease

Percutaneous Revascularisation for Unprotected Left Main Disease in High-Risk Patients: A Single Centre Experience

2008 ◽  
Vol 17 ◽  
pp. S181
Author(s):  
Sze-Yuan Ooi ◽  
Mark Pitney ◽  
Joseph Matthews ◽  
Robert Giles ◽  
Daniel Friedman ◽  
...  
Keyword(s):  
High Risk ◽  
Left Main ◽  
Left Main Disease ◽  
Single Centre ◽  
High Risk Patients ◽  
Single Centre Experience ◽  
Unprotected Left Main Disease ◽  
Risk Patients

scholarly journals TCT-354 Angiographic and Clinical Outcomes after Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity

2016 ◽  
Vol 68 (18) ◽  
pp. B145
Author(s):  
Renato Valenti ◽  
Angela Migliorini ◽  
Ruben Vergara ◽  
Guido Parodi ◽  
Eleonora Gabrielli ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Left Main ◽  
Left Main Disease ◽  
Unprotected Left Main Disease

CABG versus PCI in the Treatment of Unprotected Left Main Disease in Diabetics: A Literature Review

2021 ◽  
Vol 30 (03) ◽  
pp. 187-193
Author(s):  
Daniel Lambert ◽  
Allan Mattia ◽  
Angel Hsu ◽  
Frank Manetta
Keyword(s):  
Coronary Artery ◽  
Artery Bypass ◽  
Treatment Strategies ◽  
Coronary Intervention ◽  
Diabetic Patients ◽  
Left Main ◽  
Left Main Disease ◽  
Unprotected Left Main Disease ◽  
Long Term Follow Up ◽  
Artery Disease

AbstractThe approach to left main coronary artery disease (CAD) in diabetic patients has been extensively debated. Diabetic patients have an elevated risk of left main disease in addition to multivessel disease. Previous trials have shown increased revascularization rates in percutaneous coronary intervention compared with coronary artery bypass grafting (CABG) but overall comparable outcomes, although many of these studies were not using the latest stent technology or CABG with arterial revascularization. Our aim is to review the most recent trials that have recently published long-term follow-up, as well as other literature pertaining to left main disease in diabetic patients. Furthermore, we will be discussing some future treatment strategies that could likely create a paradigm shift in how left main CAD is managed.

scholarly journals Unprotected Left Main Disease: Stent or Surgery?

2006 ◽  
Vol 48 (8) ◽  
pp. 1727-1728 ◽  
Author(s):  
Robert Francis Bonvini ◽  
Vitali Verin ◽  
Ulrich Sigwart
Keyword(s):  
Left Main ◽  
Left Main Disease ◽  
Unprotected Left Main Disease

Persistent platelet reactivity in patients with unprotected left main disease treated by percutaneous coronary intervention

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P3058-P3058
Author(s):  
J. G. Dillinger ◽  
G. Sideris ◽  
I. Kchaou ◽  
C. Bal Dit Solier ◽  
S. Manzo-Silberman ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Platelet Reactivity ◽  
Coronary Intervention ◽  
Left Main ◽  
Left Main Disease ◽  
Percutaneous Coronary ◽  
Unprotected Left Main Disease
Sign in / Sign up

Export Citation Format

Share Document